TY - JOUR AU - Duan, Xianchun AU - Pan, Lingyu AU - Bao, Qiuyu AU - Peng, Daiyin PY - 2020 M3 - Original Research TI - UPLC-Q-TOF-MS Study of the Mechanism of THSWD for Breast Cancer Treatment JO - Frontiers in Pharmacology UR - https://www.frontiersin.org/articles/10.3389/fphar.2019.01625 VL - 10 SN - 1663-9812 N2 - Taohong Siwu decoction (THSWD) is a classic traditional Chinese medicine (TCM) prescription that is widely used in the clinical treatment of gynecological and cerebrovascular diseases. Here we used a method that coupled ultra-performance liquid chromatography to quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS) in which both positive and negative ion modes were established to investigate the major constituents in THSWD. A Waters ACQUITY UPLC BEH C18 column (2.1 mm×100 mm, 1.7 μm) was used to separate the aqueous extract of THSWD. The mobile phase consisted of 0.1% aqueous formic acid (A) and acetonitrile (B). Ninety-five components were identified in two different ion modes, including aromatic acids, flavones, polysaccharides, volatile oils monoterpene glycosides, aromatic cyanogenic glycosides, and others. Pathological changes in tumors and serum expression of interleukin-4 in a mouse model of breast cancer were detected after THSWD treatment. The results showed that THSWD had obvious therapeutic effects. This study establishes a material basis for the use of THSWD in the treatment of breast cancer. ER -